Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Elvanse Adult 40mg Hard Capsules

Discontinued
Active Ingredient:
lisdexamfetamine dimesylate
Company:  
Takeda UK Ltd See contact details
ATC code: 
N06BA12
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Elvanse Adult - Chart for ongoing monitoring of lisdexamfetamine therapy - HCP

{healthcare_pro_orange} For Healthcare Professionals
Elvanse Adult - Chart for ongoing monitoring of lisdexamfetamine therapy - HCP
{pdf_link}

Elvanse Adult - Checklist 1: lisdexamfetamine dimesylate checklist before prescribing - HCP

{healthcare_pro_orange} For Healthcare Professionals
Elvanse Adult - Checklist 1: lisdexamfetamine dimesylate checklist before prescribing - HCP
{pdf_link}

Elvanse Adult - Checklist 2: checklist for ongoing monitoring of lisdexamfetamine dimesylate therapy - HCP

{healthcare_pro_orange} For Healthcare Professionals
Elvanse Adult - Checklist 2: checklist for ongoing monitoring of lisdexamfetamine dimesylate therapy - HCP
{pdf_link}

Elvanse Adult - potential for non-medical use & diversion of prescription stimulant medications - Pt

Elvanse Adult - potential for non-medical use & diversion of prescription stimulant medications - Pt

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Takeda UK Ltd
Company image
Address
1 Kingdom Street, London, W2 6BD, UK
WWW
www.takeda.com/en-gb/
Telephone
+44 (0)3333 000 181
Medical Information e-mail
[email protected]
Drug Safety e-mail
[email protected]
Medical Information Direct Line
+44 (0)3333 000 181